S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NASDAQ:ADAP

Adaptimmune Therapeutics - ADAP Insider Trading & Ownership

$1.10
+0.01 (+0.92%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.06
▼
$1.12
50-Day Range
$1.09
▼
$1.87
52-Week Range
$1.01
▼
$2.65
Volume
562,736 shs
Average Volume
1.02 million shs
Market Capitalization
$170.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.75

Adaptimmune Therapeutics (NASDAQ:ADAP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.37%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$11,310.00
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$130,768.39

ADAP Insider Buying and Selling by Quarter

Get ADAP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Adaptimmune Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/31/2023Cintia PiccinaInsiderSell11,890$1.87$22,234.3019,535  
1/17/2023Adrian RawcliffeCEOSell10,057$1.86$18,706.0213,351  
1/17/2023John LungerInsiderSell4,440$1.86$8,258.407,264  
1/12/2023Adrian RawcliffeCEOSell18,763$1.71$32,084.7324,882  
1/12/2023William C Bertrand JrCOOSell4,973$1.71$8,503.838,121  
1/11/2023John LungerInsiderSell3,843$1.75$6,725.256,270  
1/4/2023Adrian RawcliffeCEOSell5,073$1.69$8,573.376,631  
1/4/2023John LungerInsiderSell1,100$1.69$1,859.001,725  
1/4/2023William C Bertrand JrCOOSell3,584$1.69$6,056.965,781  
9/1/2022Adrian RawcliffeCEOSell2,536$1.97$4,995.923,316  
8/1/2022John LungerInsiderSell2,983$1.77$5,279.914,829  
7/5/2022John LungerInsiderSell1,973$1.68$3,314.643,104  
6/27/2022Adrian RawcliffeCEOSell2,562$1.63$4,176.063,290  
5/20/2022Gavin WoodCFOBuy39,000$0.29$11,310.0096,000  
(Data available from 1/1/2013 forward)












ADAP Insider Trading Activity - Frequently Asked Questions

Who is on Adaptimmune Therapeutics's Insider Roster?

The list of insiders at Adaptimmune Therapeutics includes Adrian Rawcliffe, Cintia Piccina, Elliot Norry, Gavin Wood, James Noble, John Lunger, Lawrence M. Alleva, William C Bertrand Jr, and William C. Bertrand, Jr.. Learn more on insiders at ADAP.

What percentage of Adaptimmune Therapeutics stock is owned by insiders?

17.37% of Adaptimmune Therapeutics stock is owned by insiders. Learn more on ADAP's insider holdings.

Which Adaptimmune Therapeutics insiders have been buying company stock?

The following insider purchased ADAP shares in the last 24 months: Gavin Wood ($11,310.00).

How much insider buying is happening at Adaptimmune Therapeutics?

Insiders have purchased a total of 39,000 ADAP shares in the last 24 months for a total of $11,310.00 bought.

Which Adaptimmune Therapeutics insiders have been selling company stock?

The following insiders have sold ADAP shares in the last 24 months: Adrian Rawcliffe ($204,197.16), Cintia Piccina ($22,234.30), Elliot Norry ($6,765.99), John Lunger ($44,112.06), and William C Bertrand Jr ($56,085.31).

How much insider selling is happening at Adaptimmune Therapeutics?

Insiders have sold a total of 129,177 Adaptimmune Therapeutics shares in the last 24 months for a total of $333,394.82 sold.

This page (NASDAQ:ADAP) was last updated on 3/25/2023 by MarketBeat.com Staff